B-Cell Chronic Lymphocytic Leukemia Terminated Phase 1 Trials for Alvespimycin (DB12442)

Also known as: B-cell Chronic Lymphocytic Leukemia / Chronic lymphocytic leukemia / Leukemia lymphocytic chronic / CLL / Chronic lymphoid leukaemia / Lymphoid leukaemia, chronic / Lymphoid leukemia, chronic / Chronic lymphatic leukaemia / Chronic lymphoid leukemia / Leukaemia lymphocytic chronic / Chronic lymphatic leukemia / Chronic lymphocytic leukaemia NOS / Leukaemias chronic lymphocytic / Chronic lymphocytic leukaemia / Leukemia, Lymphocytic, Chronic, B-Cell / Lymphoplasmacytic leukemia / B-cell chronic lymphocytic leukaemia

IndicationStatusPhase
DBCOND0030547 (B-Cell Chronic Lymphocytic Leukemia)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01126502Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic LeukemiaTreatment